Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Tsavaris N, Skarlos D, Bacoyiannis C, Aravantinos G, Kosmas C, Retalis G, Panopoulos C, Vadiaka M, Dimitrakopoulos A, Kostantinidis K, Mitropoulos D, Bougas D, Pantazopoulos D, Kosmidis P. Tsavaris N, et al. Among authors: retalis g. J Interferon Cytokine Res. 2000 Aug;20(8):685-90. doi: 10.1089/10799900050116381. J Interferon Cytokine Res. 2000. PMID: 10954911 Clinical Trial.
Interferon-a2b reduces neo-microvascular density in the 'normal' urothelium adjacent to the tumor after transurethral resection of superficial bladder carcinoma.
Giannopoulos A, Adamakis I, Evangelou K, Giannopoulou M, Zacharatos P, Zsantoulis P, Perunovic B, Athanasiou A, Retalis G, Constandinidis C, Gorgoulis VG. Giannopoulos A, et al. Among authors: retalis g. Onkologie. 2003 Apr;26(2):147-52. doi: 10.1159/000069835. Onkologie. 2003. PMID: 12771523 Clinical Trial.
Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-alpha2b.
Gennatas C, Dardoufas C, Mouratidou D, Tsavaris N, Pouli A, Androulakis G, Philippakis M, Voros D, Batalis T, Besbeas S, Hatzistylianos G, Katsos J, Komporozos V, Legakis N, Mallas H, Peros G, Photopoulos A, Pisiotis C, Polymeneas G, Retalis G, Samanidis L, Smyrniotis V, Stamatiadis A, Vasiliou J, Andreadis H, Papadimitriou J. Gennatas C, et al. Among authors: retalis g. Ann Oncol. 2003 Mar;14(3):378-82. doi: 10.1093/annonc/mdg105. Ann Oncol. 2003. PMID: 12598341 Free article. Clinical Trial.
Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study.
Tsavaris N, Kosmas C, Vadiaka M, Zonios D, Papalambros E, Papantoniou N, Margaris H, Zografos G, Rokana S, Retalis G, Koufos C. Tsavaris N, et al. Among authors: retalis g. J Pain Symptom Manage. 2003 Sep;26(3):849-54. doi: 10.1016/s0885-3924(03)00283-5. J Pain Symptom Manage. 2003. PMID: 12967734 Free article.
Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma.
Gennatas C, Mouratidou D, Androulakis G, Georgoulias V, Tsavaris N, Philippakis M, Michailakis E, Kalofonos C, Mpesmpeas S, Katsos J, Tsitoura M, Retalis G, Mallas E, Voros D, Andreadis C, Hatzistylianos G, Pisiotis C, Kamilarios D, Kakoliris S, Komporozos V, Kannas D, Legakis N, Mpatakis T, Ntamtsios J, Papaevangelou E, Peros G, Photopoulos A, Pouli A, Prigouris S, Samanidis L, Sakellariou V, Smyrniotis V, Polymeneas G, Vasiliou J, Athanasiou A, Papadimitriou J. Gennatas C, et al. Among authors: retalis g. Tumori. 2002 Jan-Feb;88(1):32-6. Tumori. 2002. PMID: 12004847 Clinical Trial.
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Koukourakis MI, Giatromanolaki A, Kakolyris S, Froudarakis M, Georgoulias V, Retalis G, Bahlitzanakis N. Koukourakis MI, et al. Among authors: retalis g. Med Oncol. 2000 May;17(2):135-43. doi: 10.1007/BF02796209. Med Oncol. 2000. PMID: 10871820 Clinical Trial.
Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.
Koukourakis MI, Koukouraki S, Giatromanolaki A, Archimandritis SC, Skarlatos J, Beroukas K, Bizakis JG, Retalis G, Karkavitsas N, Helidonis ES. Koukourakis MI, et al. Among authors: retalis g. J Clin Oncol. 1999 Nov;17(11):3512-21. doi: 10.1200/JCO.1999.17.11.3512. J Clin Oncol. 1999. PMID: 10550149 Clinical Trial.
13 results